TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Percell Biolytica AB
Closing information (x1000 NOK)
| Closing information | 2024/08 | 2023/08 | 2022/08 |
| Turnover |
8,834
|
484 | |
| Financial expenses |
0
|
0 | |
| Earnings before taxes |
6,667
|
895 | |
| EBITDA |
6,705
|
-1,199 | |
| Total assets |
4,879
|
10,289 | |
| Current assets |
4,450
|
9,839 | |
| Current liabilities |
1,331
|
1,100 | |
| Equity capital |
3,079
|
8,662 | |
| - share capital |
98
|
92 | |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Solvency |
63.1%
|
84.2% | |
| Turnover per employee |
4,417
|
242 | |
| Profit as a percentage of turnover |
75.5%
|
184.9% | |
| Return on assets (ROA) |
136.6%
|
8.7% | |
| Current ratio |
334.3%
|
894.5% | |
| Return on equity (ROE) |
216.5%
|
10.3% | |
| Change turnover |
8,321
|
-865 | |
| Change turnover % |
-36%
|
1622%
|
-64% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.